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In this study, the immunolocalization of FosB transcription factor was investigated in
acute and chronic experimental models of seizures induced by 4-aminopyridine.
Wistar rats were injected intraperitoneally daily with 5mg/kg 4-aminopyridine for 1,
4, 8 and 12 days and sacrificed 24 h after the last injection. Corresponding control
groups received the solvent of 4-aminopyridine. Immunohistochemistry revealed an
increase in FosB immunolabelling in the frontal cortex in 4-aminopyridine-treated
animals compared to controls, both in acute and chronic time course groups. The
dentate gyrus displayed elevated FosB immunopositivity only after repeatedly
applied convulsant (4-aminopyridine), i.e. following 4, 8 and 12 days of treatment,
but no significant immunolocalization was observed in the hippocampus proper. The
neuronal localization of FosB after 12 days of 4-aminopyridine-induced convulsions
was analysed by means of FosB-parvalbumin double immunolabelling. The increased
number of double-labelled cells was significant in the frontal cortex, hilum of the
dentate fascia and region CA1 of the hippocampus. We conclude that the studied
neocortical and allocortical areas showed a different pattern of FosB immunoloca-
lization, which suggests a relative deficiency of transcriptional regulation in the
Ammon’s horn and may be responsible for distinct response to seizure-induced
cellular insult.
& 2007 Elsevier GmbH. All rights reserved.Elsevier GmbH. All rights rese
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Acute and chronic application of a great variety
of stimuli to the brain have been shown to lead to
differential responses reflecting short-term andrved.
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consequences of repeated seizure activity charac-
teristic of epilepsy differ from that of a single,
acute seizure episode. This fact is demonstrable by
the expression of transcription factors (TFs),
proteins that control gene expression in response
to receptor activation.
Fos-family TFs exert their effects via hetero-
dimeric complexes that constitute the AP-1 com-
plex and activate or repress the transcription of
many neurobiologically important target genes
(Herdegen and Leah, 1998). While c-fos and
full-length FosB are induced rapidly and transiently
in specific brain areas after different types of
stimuli, the truncated form of FosB gene, named
DFosB, codes for a highly stable protein with a
half-life of approximately 1 week and functions
as a type of ‘molecular switch’ that gradually
converts acute responses into relatively stable
adaptations that underlie long-term neural and
behavioural plasticity to repeated stimuli (Nestler
et al., 1999).
Long-lasting induction of specific Fos-family
antigens has been shown to accompany several
forms of neural and behavioural plasticity related
to drug addiction (Hope et al., 1994; Nye and
Nestler, 1996; Moratalla et al., 1996), stress
responses (Perotti et al., 2003), the clinical actions
of psychotherapeutic drugs (Hiroi and Graybiel,
1996), electroconvulsive antidepressant treatment
(Hope et al., 1994), certain lesions (Doucet et al.,
1996; Mandelzys, 1997) and epileptogenesis
(Morris et al., 2000; Madsen et al., 2006). The
investigation of seizures induced by systemically
applied kainate using reverse transcriptase–
polymerase chain reaction technique proved that
DFosB expression lasted for only 6 h and the
persistently expressed 35-kDa Fos-related protein
revealed by Western blot analysis was thus con-
sidered different from DFosB (Bing et al., 1997).
However, recent studies demonstrated that unlike
the protein, the half-life of DFosB mRNA is only
slightly longer than that of full-length FosB (Alibhai
et al., 2007). These data indicate the possibility
that the persistent expression of Fos-related anti-
gens detected after different stimuli is due to the
accumulation of the spliced variant of the FosB
gene named DFosB. Moreover, in vitro studies
confirmed that DFosB DNA encodes the expression
of all of the multiple chronic Fos-related antigens
(Chen et al., 1997).
The epileptogenic effects of the potassium
channel blocker 4-aminopyridine (4-AP) has been
extensively studied in acute experiments. c-fos
expression, that can be regarded as a tool to study
neuronal activation and seizure spread (Morgan andCurran, 1991), has a characteristic pattern and is
maximal at 1–3 h following systemic 4-AP adminis-
tration in the hippocampus and neocortex Miha´ly
et al. (2001, 2005). However, repeatedly elicited 4-
AP seizures are expected to cause qualitatively
different cellular modifications as compared to a
single seizure episode.
The present study aimed to investigate the late
distribution of FosB proteins after daily induced
seizures by intraperitoneal application of 4-AP. We
also investigated the neurochemical characteriza-
tion of a part of the FosB-positive neuronal
population, by means of double immunolabelling
for FosB and parvalbumin (PV).Materials and methods
Animals and their treatment
Generalized seizures were induced daily by the
intraperitoneal injection of 5mg/kg 4-AP dissolved
in physiological saline (0.67mg/ml) to adult Wistar
rats weighing 180–220 g. The experiments were
conducted in accordance with prevailing laws and
ethical considerations, and with the written per-
mission of the University Ethical Committee on
Animal Experiments.
A total of 24 rats were used for the experiments.
Daily 4-AP treatment was applied to four groups of
three rats for 1, 4, 8 and 12 days, respectively. The
corresponding control groups received daily injec-
tions of saline. The animals were observed for
120min following the injection and their motor
seizures were evaluated according to the Racine
scale (Racine, 1972). Five stages were distinguished
based on the severity: stage 1 – mouth and facial
movements; stage 2 – head nodding; stage 3 –
forelimb clonus; stage 4 – rearing; stage 5 – full
motor seizure (rearing and falling with loss of
postural control).
The animals were sacrificed 24 h after the last
injection. Rats were briefly anesthetized with
diethylether and perfused transcardially with
200ml of 0.1M PBS, pH 7.4, followed by 300ml of
4% phosphate-buffered paraformaldehyde, pH 7.4.
The brains were rapidly removed, postfixed in
4% paraformaldehyde for 24 h and then cryopro-
tected with 30% sucrose in 0.1M phosphate buffer
overnight at room temperature. Frozen coronal
plane sections were cut using a cryostat (Reichert-
Jung Cryocut 1800) at a thickness of 24 mm.
Every third section was processed for immuno-
histochemistry.
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Sections were incubated in 0.2% Triton X-100/PBS
for 20min, followed by washing in three changes of
PBS. Then 20% normal pig serum (NPS; Sigma) was
applied for 1 h to block nonspecific labelling.
Sections from rats injected for 1, 4 and 8 days
were used for immunohistochemical analysis of
FosB protein, while sections from the 12-days-
treated rats were used for simple FosB and double
FosB+parvalbumin immunolabelling. Since antibo-
dies selective for DFosB are not available, we
used a rabbit polyclonal antiserum raised against
an internal region of FosB (sc-48; Santa Cruz
Biotechnology), that has been shown to recognize
both FosB and DFosB (Perotti et al., 2005). The
antibody was used diluted 1:4000 in 0.05M PBS
containing 10% NPS. The sections were incubated in
the primary antibody overnight at room tempera-
ture. The biotinylated secondary antibody (goat
anti-rabbit IgG; Vector Laboratories, CA) was
diluted 1:40 in PBS, and sections were incubated
for 1 h. After additional washing, sections were
transferred to streptavidin-peroxidase (1:1000;
Jackson ImmunoResearch), and incubated for 1 h.
Then the sections were washed and processed using
0.05% 3,3-diaminobenzidine tetrahydrochloride
(DAB; Sigma) containing 0.3% nickel sulphate and
0.01% hydrogen peroxide. After 20min of incuba-
tion, the chromogen yielded a black reaction
product.
Double immunolabelling was performed using
primary antibody cocktails: mouse anti-PV (Sigma),
diluted 1:100,000 and rabbit anti-FosB (Santa Cruz
Biotechnology), diluted 1:500. The sections were
incubated in the primary antibody cocktail over-
night at room temperature, then transferred to the
secondary antibody cocktail: biotinylated anti-
mouse IgG (Sigma), diluted 1:600, and unlabelled
goat anti-rabbit IgG (Vector Laboratories) diluted
1:40. The sections were incubated for 1 h in the
secondary antibody cocktail and then transferred
to streptavidin-peroxidase (1:1000; Jackson Immu-
noResearch). The streptavidin-peroxidase was
developed by using 0.05% DAB (Sigma) with 0.01%
hydrogen peroxidase. Following a wash in TBS, the
sections were transferred to peroxidase-anti-
peroxidase (PAP; Jackson ImmunoResearch), di-
luted 1:1000, and incubated for 1 h. The PAP
was developed using 0.05% DAB (Sigma) with 0.3%
nickel sulphate and 0.01% hydrogen peroxide, as
described previously. No counterstain was
applied. The sections were dehydrated with an
ascending series of ethanol (40%, 70% and 100%),
cleared in xylene and mounted with Entellan
(Fluka).Evaluation of immunolabelling and statistical
analysis
The quantitative analysis was performed on five
histological sections per animal. Areas of interest
were selected on the basis of the same stereotaxic
coordinates (Paxinos and Watson, 1998): from
regions CA1, CA2, CA3 of the Ammon’s horn, the
granule cell layer of the dentate fascia, the hilum
of the dentate fascia, and from the frontal cortex.
In the neocortex, the areas of interest included all
neocortical layers (I–VI) from the pia mater to the
subcortical white matter. The hilum of the dentate
fascia was outlined manually, according to Amaral
(1978), and used as areas of interest. The im-
munoreactive cells were counted using a Nikon
Eclipse 600 microscope equipped with a Spot RT
Slider digital camera (1600 1200 dpi in 8 bits),
and the Image Pro Plus 4 morphometry software
(Media Cybernetics, Silver Spring, MD). Following
background subtraction, the threshold was ad-
justed so that all positively labelled cells could be
recognized. Cell counts were then normalized to
1mm2. The statistical analysis was performed with
the SPSS 9.0 computer program. Differences be-
tween control and 4-AP treated groups were
analysed by a paired t-test. P values of o0.05
were considered statistically significant.Results
4-AP-precipitated seizure behaviour
Following the injection of the convulsive dose of
4-AP, the animals displayed behavioural seizures
which lasted for 60–80min. The characteristic
symptoms occured within approximately 10min of
injection and developed gradually, as described
previously (Miha´ly et al., 1990). Initially, animals
exhibited increased exploratory activity which was
followed by tremors of the vibrissal muscles,
shivering, forelimb clonus with increasing fre-
quency moving to the development of generalized
tonic-clonic seizure with loss of postural control.
After a postictal period of 10–20min, some of the
animals displayed generalized seizure again.
The analysis of the daily elicited seizure symp-
toms according to the Racine scale proved that the
convulsion pattern changed slightly towards the
end of the experiment: decreases of the seizure
intensity were observed, i.e. after 4-AP adminis-
tration the animals developed a single full motor
seizure (stage 5) instead of two seizures, or
displayed less severe, stage 4, symptoms.
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The FosB immunohistochemistry revealed a very
weak labelling in the Ammon’s horn of both the
control and 4-AP treated rats in every time-course
group. A very small number of weakly labelled cell
nuclei were found in this hippocampal region and it
was therefore not evaluated by statistical analysis.
The dentate gyrus was characterized by more
striking FosB immunolabelling (Figure 1). There was
a significant increase in FosB-immunopositivity in
the 4-AP treated animals compared with controls
after 4, 8 and 12 days of treatment. Increase in
immunopositivity after a single 4-AP treatment did
not reach statisitical significance in comparison to
the corresponding control level (Figure 2a).
Neocortical FosB-immunoreactivity increased
significantly after 4-AP elicited convulsions at every
time point compared to controls (Figure 2b).
In the brain sections from animals treated for 12
days from both 4-AP injected and control animals,
parvalbumin-positive neurons were distributed in
every layer of the frontal cortex. In the hippocam-
pus, parvalbumin-positive neurons were present
mainly in the pyramidal layer of the Ammon’s horn
and in the hilar region, while the granule cell layer
comprised scattered parvalbumin-immunopositiveFigure 1. Low magnification photomicrographs illustrat-
ing the distribution of FosB immunoreactive cell nuclei in
the hippocampus of 4-AP treated (b, d, f) and control
(a, c, e) rats after 4 days (a, b), 8 days (c, d) and 12 days
(e, f) of treatment. Scale bar: 1mm.cells. No significant changes were revealed in the
overall number of parvalbumin-immunopositive
cells in any of the investigated brain regions after
4-AP treatment. There was, however, a significant
increase in double-labelled neurons after 4-AP
treatment in comparison to control levels in the
neocortex, hilum of the dentate gyrus and region
CA1 (Figure 3).Discussion
General evaluation of FosB immunodetection
In the present study, we analysed the effects of
daily intraperitoneal 4-AP injections on the im-
munodistribution of FosB proteins in the hippocam-
pus and frontal cortex and observed seizure
behaviour. A FosB antiserum that recognizes both
FosB and isoforms of DFosB proteins was employed.
It has been shown that full-length FosB is transi-
ently induced after stimulation and returns to basal
levels within 8–12 h, while two forms of DFosB have
been identified as having longer half-lives: the
35 kDa protein with an estimated half-life of 28 h,
and the 37 kDa protein with an estimated half-life
of 208 h (Chen et al., 1997). In order to detect the
immunodistribution of the highly stable FosB gene
products we sacrificed the experimental animals
24 h after the last injection. Thus, most of the
FosB-like immunoreactivity would be due to long
lasting forms of FosB proteins.
Repeated intraperitoneal injections of 4-AP are
thought to cause stress-related changes in the brain
which must be distinguished from the consequences
of the seizure episodes. It has been demonstrated
that after repeated stressful experiences, DFosB
expression increases in some distinct brain areas
according to the type of the stressor (Perotti et al.,
2003; Conversi et al., 2006). This is why we
compared the results of 4-AP treated and its
corresponding control group (which also received
daily intraperitoneal injections) separately for each
time-course experiment.
The pattern of immunolocalization reflected
differential adaptation of the investigated brain
regions in the four time-course groups. Following a
single injection of 4-AP, only the frontal cortex
displayed significant increase of FosB-like immu-
noreactivity. Recently, it has been suggested that
DFosB mRNA is formed by alternative splicing of the
full-length FosB mRNA and this splicing of FosB pre-
mRNA is regulated by the quantity of unspliced
transcript available to the splicing machinery
(Alibhai et al., 2007). Thus, a first stimulus may
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Figure 2. Results of FosB immunopositive cell counts in the dentate gyrus (a) and frontal cortex (b) of 4-AP injected
and control groups after 1, 4, 8 and 12 days of treatment, and results of the counting of FosB and FosB+PV double
immunopositive neurons in the frontal cortex (c), CA1 (d) and hilum of the dentate gyrus (e) in 4-AP treated and control
groups after 12 days of treatment. Asterisks denote significant differences (po0.05). S.E.M is indicated on the top of
the column.
A. Bagosi et al.422induce a FosB level high enough for the appearance
of a significant amount of DFosB that could
accumulate after further applied stimuli. Acute4-AP seizure is known to result in an intense
expression of c-fos that returns to control level
at 8 h after the stimulus (Miha´ly et al., 2005).
ARTICLE IN PRESS
Figure 3. Appearance of the PV-FosB double immunolabelling in the neocortex. Double arrows point to the double-
labelled cells, while simple arrows indicate PV-positive FosB-negative neurons and PV-negative FosB-positive cells.
Scale bar: 10 mm.
FosB transcription factor in rat seizures 423We expect that c-fos is replaced by FosB, as litera-
ture data refer to the reciprocal repression at
the promoter region of these genes (Herdegen
and Leah, 1998). It is therefore plausible that
the pattern of c-fos induction is predicting a
certain pattern of FosB expression after a single
stimulus.FosB immunolocalization in the frontal
cortex and the behavioural pattern of the
chronic 4-AP seizures
The FosB immunopositivity in the frontal cortex
was increased after 4-AP convulsions at every time
point in the experiments reported here. The
qualitative changes that are denoted by long-term
FosB expression should be considered in relation to
the transcriptional regulation of target genes.
According to the literature, glutamate receptor
subunit expression has been identified as belonging
to FosB-regulated gene products. The rearrange-
ment of the distribution of N-methyl-D-aspartate
(NMDA) receptor subunits including the upregula-
tion of NMDAR1 with decreased NMDA-induced
inward currents in pyramidal neurons and a paralleldesensitization of motor seizure after repeated
electroconvulsive seizures have been shown to be
associated with the expression of FosB in the
frontal cortex (Hiroi et al., 1998).
The intense immunolabelling of FosB in the
frontal cortex may also be correlated with a
gradual reduction in the severity of seizure
behaviour in our chronic 4-AP experiments. In the
chronically treated groups, we did observe a
gradual reduction in severity of the motor seizure
symptoms evaluated by the Racine scale. Such a
correlation could be further clarified by future
studies of changes in NMDA receptor ditribution
after 4-AP seizures.FosB immunolocalization in the hippocampus
The hippocampal immunolocalization of FosB
reflects differences between the Ammon’s horn
and dentate gyrus after repeated 4-AP convulsions.
The regions of the Ammon’s horn displayed a very
weak FosB-like immunoreactivity compared with
the dentate gyrus. This may also be indicative of an
insignificant level of the adaptive changes of NMDA
receptors, similar to those observed in the frontal
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A. Bagosi et al.424cortex and a consequent vulnerability to excito-
toxicity to glutamate. This is in accordance with a
reported vulnerability of the hippocampal regions
CA1 and CA3 to infusion of convulsive dose of 4-AP
in the hippocampus where the resulting excitotoxic
neuronal damage has been shown to be mediated
by NMDA receptor activation (Pena and Tapia,
2000).
Moreover, it has been demonstrated that seizure
preconditioning induces a much broader transcrip-
tional response in the dentate granule cell layer
than in the pyramidal cell layers and activates a
series of neuroprotective genes in the dentate
gyrus that are induced at a significantly lower level
in the Ammon’s horn (Borges et al., 2007). Many of
these genes implicated in neuronal growth and
regeneration are known to be regulated by DFosB
(Miura et al., 2005). Changes in immunoreactivity
in the dentate gyrus were not statistically signifi-
cant following the first day of seizure. However, the
chronic treatments resulted in significantly in-
creased FosB-like immunoreactivity in this hippo-
campal region. Repeated seizures are known to
induce neurogenesis of dentate granule cells
(Scharfman et al., 2003), Therefore, it is plausible
that in our experiments the strong labelling of FosB
in the dentate gyrus may also be related to this
phenomenon.
These issues seem to reflect a neuroprotective
effect of persistent presence of FosB that is
characteristic of the dentate gyrus rather than of
the hippocampus proper. However, the function of
the FosB protein is believed to be more complex, as
it has a region-specific role in the regulation of
different target genes in distinct cell populations
that are still not entirely characterized by the
existing literature. Furthermore, it is known that
depending on the level of FosB protein or the length
of time that it is expressed, it can activate or
repress gene transcription (McClung et al., 2004).
In vivo and in vitro studies revealed a large number
of target genes for DFosB, some of them in
association with cellular fates including apoptosis
(Tahara et al., 2003) and proliferation (Miura et al.,
2005). Related to injury events, DFosB has been
demonstrated to have long-lasting elevated levels
in the hippocampus after pilocarpine-induced
status epilepticus (SE) followed by recurrent
spontaneous seizures, suggesting that this TF
may play a role in epileptogenesis (Morris et al.,
2000). The increased immunoreactivity of FosB,
including in the Ammon’s horn, 8 weeks after
pilocarpine-induced SE may reflect the accumula-
tion of an isoform of DFosB that may be responsible
for late response to cellular damage, e.g. delayed
apoptosis.Alterations in the parvalbumin containing
neuronal population
The parvalbumin containing neuronal population
has been examined in earlier works that deal with
4-AP induced seizure (Miha´ly et al., 1997, 2001). PV
expressing neurons are fast-spiking GABAergic
interneurons that mediate mainly perisomatic
inhibition, alteration of their function is linked
with either hippocampal and neocortical seizure
activity (Silva et al., 2002; Sloviter, 1991).
Long-lasting seizures cause neuronal damage that
has been reported to occur even in the dentate
gyrus among parvalbumin-positive interneurons
(Kobayashi and Buckmaster, 2003).
PV-positive cells in the rat hippocampus express
protein subunits of the delayed rectifier K channel,
and the neurons are sensitive to low concentrations
of 4-AP (Du et al., 1996). Long-lasting seizures have
been shown to induce heat-shock protein expres-
sion in hilar neurons, as an indication of cellular
injury (Sloviter and Lowenstein, 1992). However, no
change in the PV mRNA content was detected in the
hippocampus and neocortex after 12 days of 4-AP
treatment (Vizi et al., 2004). The present study
revealed no significant reduction in the number of
PV immunopositive neurons and the increased
immunopositivity of FosB in this neuronal subpopu-
lation could be regarded as indicating the persis-
tent, and probably adaptive, changes in the
function of the inhibitory circuits after repeated
4-AP seizures.References
Alibhai IN, Green TA, Potashkin JA, Nestler EJ. Regulation
of FosB and DeltaFosB mRNA expression: in vivo and in
vitro studies. Brain Res 2007;1143:22–33.
Amaral DG. A Golgi study of cell types in the hilar region
of the hippocampus in the rat. J Comp Neurol
1978;182:851–914.
Bing G, Wang W, Qi Q, Feng Z, Hudson P, Jin L, et al. Long-
term expression of Fos-related antigen and transient
expression of delta FosB associated with seizures in
the rat hippocampus and striatum. J Neurochem 1997;
68:272–9.
Borges K, Shaw R, Dingledine R. Gene expression changes
after seizure preconditioning in the three major
hippocampal cell layers. Neurobiol Dis 2007;26:66–77.
Chen J, Kelz MB, Hope BT, Nakabeppu Y, Nestler E.
Chronic Fos-related antigens: stable variants of
DeltaFosB induced in brain by chronic treatments.
J Neurosci 1997;17:4933–41.
Conversi D, Bonito-Oliva A, Orsini C, Cabib S. Habituation
to the test cage influences amphetamine-induced
locomotion and Fos expression and increases FosB/
ARTICLE IN PRESS
FosB transcription factor in rat seizures 425DeltaFosB-like immunoreactivity in mice. Neuro-
science 2006;141:597–605.
Doucet JP, Nakabeppu Y, Bedard PJ, Hope BT, Nestler EJ,
Jasmin B, et al. Chronic alterations in dopaminergic
neurotransmission produce a persistent elevation of
striatal DFosB expression. Eur J Neurosci 1996;8:
365–81.
Du J, Zhang L, Weiser M, Rudy B, McBain CJ. Develop-
mental expression and functional characterization of
the potassium-channel subunit Kv3.1b in parvabumin-
containing interneurons of the rat hippocampus.
J Neurosci 1996;16:506–18.
Herdegen T, Leah JD. Inducible and constitutive tran-
scription factors in the mammalian nervous system:
control of gene expression by Jun, Fos and Krox, and
CREB/ATF proteins. Brain Res Brain Res Rev 1998;28:
370–490.
Hiroi N, Graybiel AM. Atypical and typical neuroleptic
treatments induce distinct programs of transcription
factor expression in the striatum. J Comp Neurol
1996;374:70–83.
Hiroi N, Marek GJ, Brown JR, Ye H, Saudou F, Vaidya VA,
et al. Essential role of the FosB gene in molecular,
cellular, and behavioral actions of chronic electro-
convulsive seizures. J Neurosci 1998;18:6952–62.
Hope BT, Kelz MB, Duman RS, Nestler EJ. Chronic
electroconvulsive seizure (ECS) treatment results in
expression of a long-lasting AP-1 complex in brain with
altered composition and characteristics. J Neurosci
1994;14:4318–28.
Kobayashi M, Buckmaster PS. Reduced inhibition of
dentate granule cells in a model of temporal lobe
epilepsy. J Neurosci 2003;23:2440–52.
Madsen TM, Bolwig TG, Mikkelsen JD. Differential
regulation of c-Fos and FosB in the rat brain after
amygdala kindling. Cell Mol Neurobiol 2006;26:
87–100.
Mandelzys A, Gruda MA, Bravo R, Morgan JI. Absence of a
persistently elevated 37kDa fos-related antigen and AP-
1-like DNA-binding activity in the brains of kainic acid-
treated FosB null mice. J Neurosci 1997;17:5407–15.
McClung CA, Ulery PG, Perotti LI, Zachariou V, Berton O,
Nestler EJ. DeltaFosB: a molecular switch for long-term
adaptation in the brain. Mol Brain Res 2004;132:146–54.
Miha´ly A, Bencsik K, Solymosi T. Naltrexone potentiates
4-aminopyridine seizures in the rat. J Neural Transm
(GenSect) 1990;79:59–67.
Miha´ly A, Szente M, Dubravcsik Z, Boda B, Kira´ly E, Nagy
T, et al. Parvalbumin- and calbindin-containing neu-
rons express c-fos protein in primary and secondary
(mirror) epileptic foci of the rat neocortex. Brain Res
1997;761:135–45.
Miha´ly A, Szaka´cs R, Bohata C, Dobo´ E, Krisztin-Pe´va B.
Time-dependent distribution and neuronal localization
of c-fos protein in the rat hippocampus following 4-
aminopyridine seizures. Epilepsy Res 2001;44:97–108.
Miha´ly A, Borbe´ly S, Vila´gi I, De´ta´ri L, Weiczner R, Za´dor
Z, et al. Neocortical c-fos mRNA transcription in
repeated, brief, acute seizures: is c-fos a coincidence
detector? Int J Mol Med 2005;15:481–6.Miura T, Ohnishi Y, Kurushima H, Horie H, Kadoya T,
Nakabeppu Y. Regulation of the neuronal fate by
DeltaFosB and its downstream target, galectin-1. Curr
Drug Targets 2005;6:437–44.
Moratalla R, Vallejo M, Elibol B, Graybiel AM. D1-class
dopamine receptors influence cocaine-induced persis-
tent expression of Fos-related proteins in striatum.
Neuroreport 1996;8:1–5.
Morgan JI, Curran T. Stimulus-transcription coupling in
the nervous system: involvement of the inducible
proto-oncogenes fos and jun. Annu Rev Neurosci 1991;
14:421–51.
Morris TA, Jafari N, DeLorenzo RJ. Chronic DeltaFosB
expression and increased AP-1 transcription factor
binding are associated with the long term plasticity
changes in epilepsy. Brain Res Mol Brain Res 2000;
79:138–49.
Nestler EJ, Kelz MB, Chen J. DeltaFosB: a molecular
mediator of long-term neural and behavioral plasti-
city. Brain Res 1999;835:10–7.
Nye HE, Nestler EJ. Induction of chronic Fos-related
antigens in rat brain by chronic morphine administra-
tion. Mol Pharmacol 1996;49:636–45.
Paxinos G, Watson C. The rat brain in stereotaxic
coordinates. San Diego: Academic Press; 1998.
Pena F, Tapia R. Seizures and neurodegeneration induced
by 4-aminopyridine in rat hippocampus in vivo: role of
gluatamate- and GABA-mediated neurotransmission
and of ion channels. Neuroscience 2000;101:547–61.
Perotti LI, Hadeishi Y, Barrot M, Duman RS, Nestler EJ.
Induction of DeltaFosB in reward-related brain struc-
tures after chronic stress. Abstr-Soc Neurosci 2003;29:
112–5.
Perotti LI, Bolanos CA, Choi KH, Russo SJ, Edwards S,
Ulery PG, et al. DeltaFosB accumulates in a GABAergic
cell population in the posterior tail of the ventral
tegmental area after psychostimulant treatment. Eur
J Neurosci 2005;21:2817–24.
Racine RJ. Modification of seizure activity by electrical
stimulation: II. Motor seizure. Electroencephalogr Clin
Neurophysiol 1972;32:281–94.
Scharfman HE, Sollas AL, Berger RE, Goodman JH, Pierce
JP. Perforant path activation of ectopic granule cells
that are born after pilocarpine-induced seizures.
Neuroscience 2003;121(4):1017–29.
Silva AV, Sanabria ER, Cavalheiro EA, Spreafico R.
Alterations of the neocortical GABAergic system in
the pilocarpine model of temporal lobe epilepsy:
neuronal damage and immunocytochemical changes
in chronic epileptic rats. Brain Res Bull 2002;58:
417–21.
Sloviter RS. Permanently altered hippocampal structure,
excitability, and inhibition after experimental status
epilepticus in the rat: the ‘‘dormant basket cell’’
hypothesis and its possible relevance to temporal lobe
epilepsy. Hippocampus 1991;1(1):41–66.
Sloviter RS, Lowenstein DH. Heat shock protein expres-
sion in vulnerable cells of the rat hippocampus as
an indicator of excitation-induced neuronal stress.
J Neurosci 1992;12:3004–9.
ARTICLE IN PRESS
A. Bagosi et al.426Tahara K, Tsuchimoto D, Tominaga Y, Asoh S, Ohta S,
Kitagawa M, et al. DeltaFosB, but not FosB, induces
delayed apoptosis independent of cell proliferation in
the Rat1a embryo cell line. Cell Death Differ
2003;10:496–507.Vizi S, Bagosi A, Krisztin-Peva B, Gulya K, Mihaly A.
Repeated 4-aminopyridine seizures reduce parvalbu-
min content in the medial mammillary nucleus of
the rat brain. Brain Res Mol Brain Res 2004;131:
110–8.
